Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
11.79
+0.18 (1.55%)
At close: Jun 6, 2025, 4:00 PM
12.08
+0.29 (2.46%)
After-hours: Jun 6, 2025, 6:18 PM EDT
Mesoblast Market Cap
Mesoblast has a market cap or net worth of $1.45 billion as of June 6, 2025. Its market cap has increased by 81.23% in one year.
Market Cap
1.45B
Enterprise Value
1.55B
1-Year Change
81.23%
Ranking
Category
Stock Price
$11.79
Market Cap Chart
Since November 13, 2015, Mesoblast's market cap has increased from $593.20M to $1.45B, an increase of 145.23%. That is a compound annual growth rate of 9.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 1.36B | -39.90% |
| Dec 31, 2024 | 2.26B | 1,162.26% |
| Dec 29, 2023 | 179.10M | -58.22% |
| Dec 30, 2022 | 428.70M | -31.15% |
| Dec 31, 2021 | 622.70M | -37.40% |
| Dec 31, 2020 | 994.70M | 35.19% |
| Dec 31, 2019 | 735.80M | 84.92% |
| Dec 31, 2018 | 397.90M | -27.59% |
| Dec 29, 2017 | 549.50M | 34.55% |
| Dec 30, 2016 | 408.40M | -12.21% |
| Dec 31, 2015 | 465.20M | -21.58% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 689.57B |
| Johnson & Johnson | 372.85B |
| AbbVie | 334.57B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 271.82B |
| Abbott Laboratories | 233.35B |
| Novartis AG | 230.96B |
| AstraZeneca | 225.55B |